Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TSHA

Taysha Gene Therapies, Inc.

CIK 0001806310 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$6.57
↑ 0.08 (1.23%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$1.89B
P/E Ratio
-14.54
EPS
-0.34
Dividend Yield
Not covered
52W Position
85%
Beta
1.90

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
8.91
P/S
252.71
EV/Revenue
222.24
ROE
-61.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 85%
$2.34$7.30

Latest Financials

2025-12-31 FY
Revenue
$9.77M
Net Income
-$109.00M
Total Assets
$343.32M
Free Cash Flow
-$93.83M

Recent news